Business
High Tide Welcomes Health Canada's Steps to Create Regulatory Pathway Regarding the Use of Non-Prescription CBD Products
High Tide Welcomes Health Canada's Steps to Create Regulatory Pathway Regarding the Use o...
About this update from High Tide, Inc.
[{"type":"text","content":"\n \n \n \n High Tide Welcomes Health Canada's Steps to Create Regulatory Pathway Regarding the Use of Non-Prescription CBD Products\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n \n Company's Existing International CBD Brand Portfolio Positions it Well to Service Canadian Wellness Market\n \n \n \n \n \n \n CALGARY, AB\n \n \n ,\n \n \n July 29, 2022\n \n \n /CNW/ - High Tide Inc. (\"\n \n High Tide\n \n \" or the \"\n \n Company\n \n \") (Nasdaq: HITI) (TSXV: HITI) (FSE: 2LYA) a leading retail-focused cannabis company with bricks-and-mortar as well as global e-commerce assets, welcomes the decision by Health Canada to begin consultations and gather stakeholder feedback regarding the development of a potential regulatory pathway that would permit cannabidiol (\"\n \n CBD\n \n \") as a medicinal ingredient in certain health products, regulated under the\n \n Food and Drugs Act\n \n (\n \n Canada\n \n ), which would not require a prescription. The consultation will seek input on regulatory or policy changes pertaining to non-prescription health products containing CBD, including those intended for human use and/or animal use. This decision to begin consultations followed the release of the\n \n \n Report of the Science Advisory Committee on Health Products Containing Cannabis\n \n \n , which detailed a series of research-informed recommendations that are intended to guide Health Canada's development of regulations to permit the sale of non-prescription CBD products in certain over the counter settings.\n \n \n \n \n \n \n \n \n \n \"I am encouraged to see that Health Canada is taking these long-awaited steps towards the creation of regulations which will allow Canadian consumers to safely access non-prescription health products containing CBD. Although\n \n Canada\n \n was an early mover in modernizing laws and regulations covering cannabinoids, we have since been surpassed by numerous countries including the U.K., U.S., and\n \n Australia\n \n in making non-psychoactive CBD health products mor...